• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Bye bye alessandro

Quote








Onc shit the bed not getting on the immuno train fast enough. Theyre no longer driving the company bus in profits/pipeline. Vas came in and told those prescious little snowflakes they gotta play nice with the rest of the company and share resources and get in the fold. Their little feifdom is over and AR couldnt accept that, so he left.

Onc unit was bloated with damn near everyone being a VP. Gotta trim that fat.
 








anonymous said:
Onc shit the bed not getting on the immuno train fast enough. Theyre no longer driving the company bus in profits/pipeline. Vas came in and told those prescious little snowflakes they gotta play nice with the rest of the company and share resources and get in the fold. Their little feifdom is over and AR couldnt accept that, so he left.

Onc unit was bloated with damn near everyone being a VP. Gotta trim that fat.
Click to expand...
So Epstein was not the wunderkind? And he was essentially relieved on his command?
 




Probably was asked to leave after a spectacular career. He failed to see immunotherapy being the huge success it has become although there is incredible hype and not so incredible toxicity. Many others failed to see it as well and are all playing catch up
 




anonymous said:
Probably was asked to leave after a spectacular career. He failed to see immunotherapy being the huge success it has become although there is incredible hype and not so incredible toxicity. Many others failed to see it as well and are all playing catch up
Click to expand...
Epstein made a huge bet with kinase inhibitors and the GSK oncology portfolio.
 








Top Bottom
Back
Quote